{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:34:47Z","timestamp":1793147687913,"version":"4.5.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:00:00Z","timestamp":1793059200000},"content-version":"vor","delay-in-days":26,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015979","name":"Pelotonia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015979","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006652","name":"University of Michigan National Center for Institutional Diversity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006652","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008637","name":"National Cancer Institute Center for Strategic Scientific Initiatives","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","redjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.ijrobp.2026.10.012","type":"journal-article","created":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:23:48Z","timestamp":1792682628000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A Phase 1 Trial Investigating the Addition of Papaverine to Stereotactic Body Radiotherapy (SBRT) for Hypoxic Radiosensitization of Lung Tumors"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2820-4895","authenticated-orcid":false,"given":"Jeremy","family":"Brownstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Xu-Welliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sung Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Haglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Benej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Papandreou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Qing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Graves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Denko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"782","key":"10.1016\/j.ijrobp.2026.10.012_bib0001","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1098\/rspb.1933.0044","article-title":"The action of radium on cancer cells II - Some factors determining the susceptibility of cancer cells to radium","volume":"113","author":"Crabtree","year":"1933","journal-title":"P R Soc Lond B-Conta"},{"issue":"105","key":"10.1016\/j.ijrobp.2026.10.012_bib0002","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1259\/0007-1285-9-105-606","article-title":"A factor of importance in the radio sensitivity of tumours","volume":"9","author":"Mottram","year":"1936","journal-title":"The British Journal of Radiology"},{"issue":"312","key":"10.1016\/j.ijrobp.2026.10.012_bib0003","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1259\/0007-1285-26-312-638","article-title":"The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy","volume":"26","author":"Gray","year":"1953","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.ijrobp.2026.10.012_bib0004","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1080\/095530098141726","article-title":"Evidence for a hypoxic fixation reaction leading to the induction of ssb and dsb in irradiated DNA","volume":"74","author":"Prise","year":"1998","journal-title":"Int J Radiat Biol"},{"issue":"2","key":"10.1016\/j.ijrobp.2026.10.012_bib0005","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0167-8140(98)00044-9","article-title":"Oxygenation predicts radiation response and survival in patients with cervix cancer","volume":"48","author":"Fyles","year":"1998","journal-title":"Radiother Oncol"},{"issue":"19","key":"10.1016\/j.ijrobp.2026.10.012_bib0006","first-page":"4509","article-title":"Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix","volume":"56","author":"Hockel","year":"1996","journal-title":"Cancer Res"},{"issue":"1","key":"10.1016\/j.ijrobp.2026.10.012_bib0007","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0167-8140(00)00223-1","article-title":"A confirmatory prognostic study on oxygenation status and loco-regional control in advanced head and neck squamous cell carcinoma treated by radiation therapy","volume":"57","author":"Nordsmark","year":"2000","journal-title":"Radiother Oncol"},{"issue":"26","key":"10.1016\/j.ijrobp.2026.10.012_bib0008","doi-asserted-by":"crossref","first-page":"4066","DOI":"10.1200\/JCO.2007.12.7878","article-title":"Hypoxic radiosensitization: adored and ignored","volume":"25","author":"Overgaard","year":"2007","journal-title":"J Clin Oncol"},{"issue":"10-11","key":"10.1016\/j.ijrobp.2026.10.012_bib0009","first-page":"509","article-title":"Clinical evaluation of nitroimidazoles as modifiers of hypoxia in solid tumors","volume":"6","author":"Overgaard","year":"1994","journal-title":"Oncol Res"},{"issue":"9","key":"10.1016\/j.ijrobp.2026.10.012_bib0010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s12032-016-0814-0","article-title":"Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours","volume":"33","author":"St\u0119pie\u0144","year":"2016","journal-title":"Medical Oncology"},{"issue":"42","key":"10.1016\/j.ijrobp.2026.10.012_bib0011","doi-asserted-by":"crossref","first-page":"10756","DOI":"10.1073\/pnas.1808945115","article-title":"Papaverine and its derivatives radiosensitize solid tumors by inhibiting mitochondrial metabolism","volume":"115","author":"Benej","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"10.1016\/j.ijrobp.2026.10.012_bib0012","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13071696","article-title":"Pharmacological Regulation of Tumor Hypoxia in Model Murine Tumors and Spontaneous Canine Tumors","volume":"13","author":"Benej","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"9","key":"10.1016\/j.ijrobp.2026.10.012_bib0013","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamaoncol.2018.1258","article-title":"Long-term results of stereotactic body radiation therapy in medically inoperable stage I non\u2013small cell lung cancer","volume":"4","author":"Timmerman","year":"2018","journal-title":"JAMA oncology"},{"issue":"3","key":"10.1016\/j.ijrobp.2026.10.012_bib0014","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jtho.2016.11.002","article-title":"A histologic basis for the efficacy of SBRT to the lung","volume":"12","author":"Woody","year":"2017","journal-title":"Journal of Thoracic Oncology"},{"issue":"5","key":"10.1016\/j.ijrobp.2026.10.012_bib0015","first-page":"227","article-title":"Pharmacokinetics of papaverine in man","volume":"15","author":"Ritschel","year":"1977","journal-title":"International journal of clinical pharmacology and biopharmacy"},{"issue":"2","key":"10.1016\/j.ijrobp.2026.10.012_bib0016","first-page":"156","article-title":"Examining correlations of oxygen sensitive MRI (BOLD\/TOLD) with [(18)F]FMISO PET in rat prostate tumors","volume":"9","author":"Zhou","year":"2019","journal-title":"Am J Nucl Med Mol Imaging"},{"issue":"5","key":"10.1016\/j.ijrobp.2026.10.012_bib0017","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/jmri.23891","article-title":"Blood oxygenation level-dependent (BOLD) contrast magnetic resonance imaging (MRI) for prediction of breast cancer chemotherapy response: a pilot study","volume":"37","author":"Jiang","year":"2013","journal-title":"Journal of Magnetic Resonance Imaging"},{"issue":"2","key":"10.1016\/j.ijrobp.2026.10.012_bib0018","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/153303460700600207","article-title":"RT_Image: an open-source tool for investigating PET in radiation oncology","volume":"6","author":"Graves","year":"2007","journal-title":"Technology in cancer research & treatment"},{"issue":"17","key":"10.1016\/j.ijrobp.2026.10.012_bib0019","doi-asserted-by":"crossref","first-page":"4291","DOI":"10.1158\/1078-0432.CCR-16-0592","article-title":"Bayesian optimal interval design: a simple and well-performing design for phase I oncology trials","volume":"22","author":"Yuan","year":"2016","journal-title":"Clinical Cancer Research"},{"issue":"3","key":"10.1016\/j.ijrobp.2026.10.012_bib0020","first-page":"507","article-title":"Bayesian optimal interval designs for phase I clinical trials","volume":"64","author":"Liu","year":"2015","journal-title":"Journal of the Royal Statistical Society: Series C (Applied Statistics)"},{"key":"10.1016\/j.ijrobp.2026.10.012_bib0021","series-title":"Clinical Radiation Oncology Indications, Techniques, and results","first-page":"295","article-title":"Cancer of the intrathorax","author":"Choi","year":"2000"},{"key":"10.1016\/j.ijrobp.2026.10.012_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109664","article-title":"Local control correlates with overall survival in radiotherapy for early-stage non-small cell lung cancer: A systematic review","volume":"183","author":"Sanuki","year":"2023","journal-title":"Radiotherapy and Oncology"},{"issue":"12","key":"10.1016\/j.ijrobp.2026.10.012_bib0023","doi-asserted-by":"crossref","first-page":"6347","DOI":"10.1118\/1.3639137","article-title":"Tumor hypoxia is an important mechanism of radioresistance in hypofractionated radiotherapy and must be considered in the treatment planning process","volume":"38","author":"Carlson","year":"2011","journal-title":"Med Phys"},{"issue":"2","key":"10.1016\/j.ijrobp.2026.10.012_bib0024","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.ijrobp.2010.04.070","article-title":"Stereotactic ablative radiotherapy should be combined with a hypoxic cell radiosensitizer","volume":"78","author":"Brown","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.ijrobp.2026.10.012_bib0025","article-title":"Defining hypoxia in cancer: A landmark evaluation of hypoxia gene expression signatures","volume":"5","author":"Di Giovannantonio","year":"2025","journal-title":"Cell Genom"},{"issue":"1","key":"10.1016\/j.ijrobp.2026.10.012_bib0026","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s13059-016-0999-8","article-title":"Genomic alterations underlie a pan-cancer metabolic shift associated with tumour hypoxia","volume":"17","author":"Haider","year":"2016","journal-title":"Genome Biol"},{"issue":"1","key":"10.1016\/j.ijrobp.2026.10.012_bib0027","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20231106","article-title":"Hypoxia is linked to acquired resistance to immune checkpoint inhibitors in lung cancer","volume":"222","author":"Robles-Oteiza","year":"2025","journal-title":"J Exp Med"},{"key":"10.1016\/j.ijrobp.2026.10.012_bib0028","doi-asserted-by":"crossref","DOI":"10.1017\/erm.2026.10044","article-title":"Hypoxia and HIF signalling in tumour microenvironment: linking immune evasion, metabolic rewiring and epigenetic regulation","volume":"28","author":"Fawzul Ameer","year":"2026","journal-title":"Expert Rev Mol Med"},{"issue":"10","key":"10.1016\/j.ijrobp.2026.10.012_bib0029","doi-asserted-by":"crossref","first-page":"5074","DOI":"10.1172\/JCI137552","article-title":"HIFs, angiogenesis, and metabolism: elusive enemies in breast cancer","volume":"130","author":"de Heer","year":"2020","journal-title":"J Clin Invest"},{"issue":"8","key":"10.1016\/j.ijrobp.2026.10.012_bib0030","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1080\/15548627.2019.1687213","article-title":"Hypoxia-induced autophagy drives colorectal cancer initiation and progression by activating the PRKC\/PKC-EZR (ezrin) pathway","volume":"16","author":"Qureshi-Baig","year":"2020","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.ijrobp.2026.10.012_bib0031","first-page":"189","article-title":"Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis","volume":"123","author":"Chaturvedi","year":"2013","journal-title":"J Clin Invest"},{"issue":"5","key":"10.1016\/j.ijrobp.2026.10.012_bib0032","first-page":"941","article-title":"Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma","volume":"56","author":"Brizel","year":"1996","journal-title":"Cancer Res"},{"issue":"9","key":"10.1016\/j.ijrobp.2026.10.012_bib0033","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1158\/1078-0432.CCR-20-4128","article-title":"Mitochondrial Inhibitor Atovaquone Increases Tumor Oxygenation and Inhibits Hypoxic Gene Expression in Patients with Non-Small Cell Lung Cancer","volume":"27","author":"Skwarski","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2026.10.012_bib0034","article-title":"Hypoxic Gene Expression Signature as a Predictor of Recurrence and Mortality in Early-Stage Non\u2013Small Cell Lung Cancer Treated With Stereotactic Body Radiation Therapy","volume":"9","author":"Eustace","year":"2025","journal-title":"JCO Precision Oncology"},{"issue":"21","key":"10.1016\/j.ijrobp.2026.10.012_bib0035","doi-asserted-by":"crossref","first-page":"23140","DOI":"10.1021\/acs.jmedchem.5c02014","article-title":"Development of Selective and Soluble Mitochondrial Complex 1 Inhibitors Derived from Papaverine for Radiosensitization of Cancer","volume":"68","author":"Haines","year":"2025","journal-title":"Journal of Medicinal Chemistry"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626043907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301626043907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:06:14Z","timestamp":1793145974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301626043907"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":35,"alternative-id":["S0360301626043907"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.10.012","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Phase 1 Trial Investigating the Addition of Papaverine to Stereotactic Body Radiotherapy (SBRT) for Hypoxic Radiosensitization of Lung Tumors","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2026.10.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}